Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 18, 2003. The report details changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs) resulting from movements in employee benefit funds and share option plans.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on shareholding changes and transaction prices for specific dates.
- Share Prices: ADRs traded at an average of $35.85 (Feb 13) and $36.38 (Feb 14). Ordinary shares were sold at £11.025 and £11.04 (Feb 13).
- Share Counts: The US Retirement Savings Plan held between 18,194,259 and 18,265,581 ADRs during the reporting window.
Material Changes
Material changes reported relate to the volume of shares held by employee funds and specific directors:
- US Retirement Savings Plan: Holdings decreased by 46,399 ADRs on February 13, then increased by 71,322 ADRs on February 14.
- SmithKline Beecham Employee Benefit Trust: Transferred 347,491 ordinary shares to participants of the 1991 Share Option Plan. The trust also sold a total of 163,368 ordinary shares on February 13.
- Director Activity: Dr. J.P. Garnier increased his personal interest by 80 ADRs on February 14.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a statutory disclosure of director share interests and does not contain forward-looking financial statements.
Important Facts for Investors
- Directors Dr. J.P. Garnier and Mr. J.D. Coombe hold interests in the company's shares indirectly through discretionary employee funds.
- Significant share transfers occurred from the SmithKline Beecham Employee Benefit Trust to share option plan participants.
- Share price data indicates trading activity for ADRs in the $35.85–$36.38 range and ordinary shares at approximately £11.03 during mid-February 2003.